Nephron Pharmaceuticals Corp. Recalls

Overview of recall records associated with Nephron Pharmaceuticals Corp., including dates, categories and classifications where available.

3recall records

Oct 21, 2015latest record date

Aug 15, 2012earliest record date

Recall history in this database

Classification mix: Class II: 3.

DrugOct 21, 2015

Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution recall — FDA D-0010-2016

Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process

Class IIFDA: TerminatedNephron Pharmaceuticals Corp.

DrugOct 30, 2013

Albuterol Sulfate Inhalation Solution, 0.083% 2.5 mg/3 mL for Oral Inhalation Only recall — FDA D-66462-001

Lack of Assurance of Sterility: Nephron Pharmaceuticals Corporation conducted a routine periodic aseptic process simulation and discovered bacterial growth in a number of media fill vials,…

Class IIFDA: TerminatedNephron Pharmaceuticals Corp.

DrugAug 15, 2012

Albuterol Sulfate Inhalation Solution, 0.083%, 2.5 mg/3 mL Sterile Unit-Dose Vials, 60-count recall — FDA D-1446-2012

Lack of Assurance of Sterility

Class IIFDA: TerminatedNephron Pharmaceuticals Corp.

Understanding this recall history

This page summarizes recall records in which the official source identifies Nephron Pharmaceuticals Corp. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.